HEMATOPOIETIC PROGENITOR CELLS, CORD BLOOD- human cord blood hematopoietic progenitor cell liquid United States - English - NLM (National Library of Medicine)

hematopoietic progenitor cells, cord blood- human cord blood hematopoietic progenitor cell liquid

clinimmune labs, university of colorado blood bank - human cord blood hematopoietic progenitor cell (unii: xu53vk93mc) (human cord blood hematopoietic progenitor cell - unii:xu53vk93mc) - human cord blood hematopoietic progenitor cell 500000000 in 30 ml - hpc (hematopoietic progenitor cells), cord blood is an allogeneic cord blood hematopoietic progenitor cell therapy indicated for use in unrelated donor hematopoietic progenitor stem cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment. the risk benefit assessment for an individual patient depends on the patient characteristics, including disease, stage, risk factors, and specific manifestations of the disease, on characteristics of the graft, and on other available treatments or types of hematopoietic progenitor cells. hpc, cord blood is contraindicated in patients with known hypersensitivity to dimethyl sulfoxide (dmso), dextran 40 or plasma proteins. [see description (11) and dosage and administration (2.2)] pregnancy category c. animal reproduction studies have not been conducted with hpc, cord

DIPROGENTA OINTMENT Israel - English - Ministry of Health

diprogenta ointment

organon pharma israel ltd., israel - betamethasone as dipropionate; gentamicin as sulfate - ointment - betamethasone as dipropionate 0.5 mg / 1 g; gentamicin as sulfate 1 mg / 1 g - topical treatment of dermatosis complicated by secondary infection caused by organisms sensitive to gentamicin

DIPROGENTA CREAM Israel - English - Ministry of Health

diprogenta cream

organon pharma israel ltd., israel - betamethasone as dipropionate; gentamicin (as sulfate) - cream - gentamicin (as sulfate) 1 mg/g; betamethasone as dipropionate 0.5 mg/g - corticosteroids, potent, combinations with antibiotics - for the relief of the inflammatory manifestations of corticosteroid-responsive dermatoses when complicated by secondary infections caused by organisms susceptible to gentamycin.

ALLOCORD- human cord blood hematopoietic progenitor cell injection, solution United States - English - NLM (National Library of Medicine)

allocord- human cord blood hematopoietic progenitor cell injection, solution

ssm cardinal glennon children's medical center st. louis cord blood bank - human cord blood hematopoietic progenitor cell (unii: xu53vk93mc) (human cord blood hematopoietic progenitor cell - unii:xu53vk93mc) - human cord blood hematopoietic progenitor cell 500000000 in 35 ml - allocord, hpc (hematopoietic progenitor cell), cord blood, is an allogeneic cord blood hematopoietic progenitor cell therapy indicated for use in unrelated donor hematopoietic progenitor stem cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment. the risk benefit assessment for an individual patient depends on the patient characteristics, including disease, stage, risk factors, and specific manifestations of the disease, on characteristics of the graft, and on other available treatments or types of hematopoietic progenitor cells. none pregnancy category c. animal reproduction studies have not been conducted with allocord. it is also not known whether allocord can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. there are no adequate and well-controlled st

PROGENA ATTENTION SPAN- anacardium orientale, calcarea phosphorica, carcinosin, iodium, stramonium, tarentula hispana, veratrum United States - English - NLM (National Library of Medicine)

progena attention span- anacardium orientale, calcarea phosphorica, carcinosin, iodium, stramonium, tarentula hispana, veratrum

meditrend, inc. dba progena professional formulations - semecarpus anacardium juice (unii: y0f0bu8rdu) (semecarpus anacardium juice - unii:y0f0bu8rdu), tribasic calcium phosphate (unii: 91d9gv0z28) (calcium cation - unii:2m83c4r6zb), human breast tumor cell (unii: c62oo7vd9k) (human breast tumor cell - unii:c62oo7vd9k), iodine (unii: 9679tc07x4) (iodine - unii:9679tc07x4), datura stramonium (unii: g6w4f0v8z3) (datura stramonium - unii:g6w4f0v8z3), lycosa tarantula (unii: 86m454l2tt) (lycosa tarantula - unii:86m454l2tt), veratrum album root (unii: qns6w5us1 - semecarpus anacardium juice 30 [hp_c] in 1 ml - purpose: formulated to temporarily help the body's ability to concentrate, remain focused, improve self-esteem and confidence, and lessen restlessness. use: this product is a homeopathic dilution formulated for the temporary relief of symptoms associated with attention deficit disorders (with or without hyperactivity).

HEMACORD- human cord blood hematopoietic progenitor cell injection United States - English - NLM (National Library of Medicine)

hemacord- human cord blood hematopoietic progenitor cell injection

new york blood center - human cord blood hematopoietic progenitor cell (unii: xu53vk93mc) (human cord blood hematopoietic progenitor cell - unii:xu53vk93mc) - human cord blood hematopoietic progenitor cell 500000000 in 25 ml - hemacord, hpc (hematopoietic progenitor cell), cord blood, is an allogeneic cord blood hematopoietic progenitor cell therapy indicated for use in unrelated donor hematopoietic progenitor stem cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment. the risk benefit assessment for an individual patient depends on the patient characteristics, including disease, stage, risk factors, and specific manifestations of the disease, on characteristics of the graft, and on other available treatments or types of hematopoietic progenitor cells. none pregnancy category c. animal reproduction studies have not been conducted with hemacord. it is also not known whether hemacord can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. there are no adequate and well-controlled st

PROGENA IMMUGEN- aralia quinquefolia, echinacea, phytolacca decandra, ascorbic acid, beta carotene, glandula suprarenalis, pyrid United States - English - NLM (National Library of Medicine)

progena immugen- aralia quinquefolia, echinacea, phytolacca decandra, ascorbic acid, beta carotene, glandula suprarenalis, pyrid

meditrend, inc. dba progena professional formulations - american ginseng (unii: 8w75vcv53q) (american ginseng - unii:8w75vcv53q), echinacea, unspecified (unii: 4n9p6cc1dx) (echinacea, unspecified - unii:4n9p6cc1dx), phytolacca americana root (unii: 11e6vi8veg) (phytolacca americana root - unii:11e6vi8veg), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), .beta.-carotene (unii: 01yae03m7j) (.beta.-carotene - unii:01yae03m7j), sus scrofa adrenal gland (unii: 398iyq16yv) (sus scrofa adrenal gland - unii:398iyq16yv), pyridoxine hydrochloride - american ginseng 3 [hp_x] in 1 ml - purpose: improve immune function. use: this product is a homeopathic dilution formulated to help improve immune function in infants, children and adults.

CORDCYTE- human cord blood hematopoietic progenitor cell injection, suspension United States - English - NLM (National Library of Medicine)

cordcyte- human cord blood hematopoietic progenitor cell injection, suspension

lifesouth community blood centers, inc. - human cord blood hematopoietic progenitor cell (unii: xu53vk93mc) (human cord blood hematopoietic progenitor cell - unii:xu53vk93mc) - human cord blood hematopoietic progenitor cell 500000000 in 25 ml - cordcyte, hpc (hematopoietic progenitor cell), cord blood is an allogeneic cord blood hematopoietic progenitor cell therapy indicated for use in unrelated donor hematopoietic progenitor stem cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment. the risk benefit assessment for an individual patient depends on the patient characteristics, including disease, stage, risk factors, and specific manifestations of the disease, on characteristics of the graft, and on other available treatments or types of hematopoietic progenitor cells. none. pregnancy category c. animal reproduction studies have not been conducted with cordcyte. it is also not known whether cordcyte can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. there are no adequate and well-controlled st

PROGENA ADRENAL PLUS- atropinum sulphuricum, berberis vulgaris, bryonia, carduus marianus, chelidonium majus, echinacea, glandul United States - English - NLM (National Library of Medicine)

progena adrenal plus- atropinum sulphuricum, berberis vulgaris, bryonia, carduus marianus, chelidonium majus, echinacea, glandul

meditrend, inc. dba progena professional formulations - atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i), berberis vulgaris root bark (unii: 1th8q20j0u) (berberis vulgaris root bark - unii:1th8q20j0u), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), silybum marianum seed (unii: u946sh95ee) (silybum marianum seed - unii:u946sh95ee), chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), echinacea, unspecified (unii: 4n9p6cc1dx) (echinacea, unspecified - unii:4n9p6cc1dx), sus scrofa adrenal gla - atropine sulfate 6 [hp_x] in 1 ml - purpose: support for the body's endocrine and organ system use: this product is a homeopathic dilution, formulated to support the body's endocrine and organ system.

DUCORD- human cord blood hematopoietic progenitor cell solution United States - English - NLM (National Library of Medicine)

ducord- human cord blood hematopoietic progenitor cell solution

duke university school of medicine, carolinas cord blood bank - human cord blood hematopoietic progenitor cell (unii: xu53vk93mc) (human cord blood hematopoietic progenitor cell - unii:xu53vk93mc) - human cord blood hematopoietic progenitor cell 900000000 in 25 ml - ducord, hpc (hematopoietic progenitor cell), cord blood, is an allogeneic cord blood hematopoietic progenitor cell therapy indicated for use in unrelated donor hematopoietic progenitor stem cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment. the risk benefit assessment for an individual patient depends on the patient characteristics, including disease, stage, risk factors, and specific manifestations of the disease, on characteristics of the graft, and on other available treatments or types of hematopoietic progenitor cells. none. risk summary there are no data with ducord use in pregnant women to inform a product-associated risk. animal reproduction studies have not been conducted with ducord. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in